Thats right so it must be coming SOON. Remember the positive results they have to date.
$10 Million Equity Purchase and Why Southridge has partnered with Entest, Statement from Southridge:
Entest BioMedical (ENTB) has established a solid foundation through its extensive network within the scientific community, veterinarian hospitals, research facilities and various institutions. The cancer treatment technology, coupled with the Company’s strategic partners and joint ventures, provide a solid foundation for marketing Entest’s canine applications.
Given the team’s dedication and focus on the advancement of Immuno-Therapeutic Cancer Vaccine, Entest expects to generate near-term revenue, while creating substantial value for shareholders.
Market Data 
Markets 
AI
